Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

The Regulatory Roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer

Author(s): Jiayuan Qu, Mohammad Amjad Kamal and Chengfu Yuan*

Volume 25, Issue 8, 2019

Page: [856 - 861] Pages: 6

DOI: 10.2174/1381612825666190404122154

Price: $65

Abstract

Background: Ovarian cancer is the most malignant tumor in gynecological tumors, with low five-year survival rate. The main reasons are diagnosis at advanced stages (the early symptoms are uncharacteristic, and most are diagnosedlate.), relapse, and resistance to existing chemotherapy drugs.

Methods: Search strategy was performed in the following steps. Firstly, LncRNA related to ovarian cancer was retrieved by using the LncRNA Disease database, and articles were searched by searching keywords: ovarian cancer, drug resistance, and LncRNA retrieved from the LncRNA Disease database.

Results/Conclusion: With the development of the study on drug resistance of ovarian cancer, the role of LncRNAs as sensitive biomarker and therapeutic target has emerged, providing a direction for precision medicine of ovarian cancer resistance.

Keywords: Ovarian cancer, chemoresistance, long non-coding RNA, LncRNA, drug resistance, gynecological tumors.


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy